Hospital Management Corporations: Nearly 50% in the Red Due to Worsening Profitability; Revenue Slightly Up, Profits Down Over 1 Trillion Yen Since COVID

News Highlights

A survey by Tokyo Shoko Research has revealed a situation where nearly 50% of hospital management corporations are operating in the red. This is attributed to total revenue remaining only slightly increased, while medical profits have seen a significant decrease of over 1 trillion yen since the COVID-19 pandemic. This situation suggests that many medical institutions are facing severe management challenges.

M&A Medical Editorial Department’s Perspective

The latest survey by Tokyo Shoko Research highlights the harsh reality of medical institution management. The fact that medical profits have decreased by over 1 trillion yen since the COVID-19 pandemic suggests not just a temporary downturn, but a structural decline in earning capacity. In particular, the figure of nearly 50% of corporations being in the red indicates that even previously stable medical institutions may have their financial foundations shaken. Under these circumstances, it is essential for medical institutions considering M&A or business succession to accurately grasp their own revenue structure and future risks at an earlier stage and collaborate with experts. For example, in cases like XX Hospital, which plays a central role in regional healthcare, the trend of declining profits, in addition to the challenge of a lack of successor, could become a major obstacle to business continuity. Early decision-making is extremely important from the perspective of succession under more favorable terms and maintaining regional healthcare.

Points Raised by This News

• The specific figure of over 1 trillion yen in decreased medical profits since the COVID-19 pandemic suggests fundamental issues in the revenue structure of medical institutions.
• The situation where nearly 50% of corporations are in the red suggests that the impact is extending even to medical institutions that have previously had stable management.
• The fact that profits have significantly decreased while revenue has only slightly increased suggests a combination of factors, such as a rigid cost structure and the impact of medical fee revisions.
• For medical institutions supporting regional healthcare, such as XX Hospital, the risk of business continuity is increasing when declining profitability and a lack of successors occur simultaneously.

Practical Questions Arising from This News

• Specifically, what changes in the cost structure led to the decrease in medical profits exceeding 1 trillion yen?
• With nearly 50% of corporations in the red, what is the optimal timing for considering M&A?
• What are the concrete steps for medical institutions lacking successors to successfully conduct M&A amidst this trend of declining profitability?

If You Feel “Should I Consult?”

How has your institution’s medical profit changed since the COVID-19 pandemic? If revenue stagnation continues, or if cost increases are significant, it is wise to consult with experts early on. Especially when combined with challenges such as a lack of successors, considering M&A or business succession options before the management situation deteriorates increases the likelihood of securing more options and favorable terms. Let’s start by accurately assessing the current financial situation.

M&A Medical (CentralMedience Inc.) is certified by the Small and Medium Enterprise Agency as an M&A support institution and provides support for the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here